Live from the 2013 San Antonio Breast Cancer Symposium, our onsite reporters checked in with meeting attendees to find out the "most interesting thing" they had learned so far. From identifying predictive signatures via genomic data to treating postmenopausal women with bisphosphonates, passing oncologists shared their favorite, potentially practice-changing highlights.